These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 6181640

  • 1. Evidence of a correlation between thyrotrophin receptor binding inhibition and thyroid adenylate cyclase activation by immunoglobulins in Graves' disease before and during long-term antithyroid treatment.
    Bliddal H, Bech K, Hyltoft Petersen P, Siersbaek-Nielsen K, Friis T.
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):35-40. PubMed ID: 6181640
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T.
    J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy.
    Bliddal H, Kirkegaard C, Siersbaek-Nielsen K, Friis T.
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):364-9. PubMed ID: 6170200
    [Abstract] [Full Text] [Related]

  • 4. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
    Docter R, Bos G, Visser TJ, Hennemann G.
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [Abstract] [Full Text] [Related]

  • 8. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment].
    Uno C, Nishikawa M.
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar 20; 64(3):206-15. PubMed ID: 2456230
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
    Wägar G, Mäkinen T, Lamberg BA, Gordin A, Apter L, Pekonen F.
    Ann Clin Res; 1982 Apr 20; 14(2):83-9. PubMed ID: 6184007
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep 20; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 12. Changes in thyrotropin binding inhibiting immunoglobulins (TBII) in sera of patients with Graves' disease at the time of relapse or exacerbation.
    Uchimura H, Akimoto N, Mitsuhashi T, Kubota K, Kuzuya N, Imai Y, Ikeda H, Matsuzaki F, Kumagai LF.
    J Endocrinol Invest; 1986 Feb 20; 9(1):37-42. PubMed ID: 2422245
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct 20; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 15. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, Kendall-Taylor P.
    Q J Med; 1988 Feb 20; 66(250):175-89. PubMed ID: 2902655
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ, Wiersinga WM, Prummel MF.
    J Clin Endocrinol Metab; 2003 Sep 20; 88(9):4135-8. PubMed ID: 12970276
    [Abstract] [Full Text] [Related]

  • 17. Thyroid stimulating immunoglobulins in patients in long-term remission after Graves' disease.
    Bliddal H, Bech K, Kirkegaard C.
    Horm Metab Res; 1984 Nov 20; 16(11):602-5. PubMed ID: 6210237
    [Abstract] [Full Text] [Related]

  • 18. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep 20; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 19. Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs.
    Massart C, Orgiazzi J, Maugendre D.
    Clin Chim Acta; 2001 Feb 20; 304(1-2):39-47. PubMed ID: 11165197
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs.
    Michelangeli V, Poon C, Taft J, Newnham H, Topliss D, Colman P.
    Thyroid; 1998 Feb 20; 8(2):119-24. PubMed ID: 9510119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.